3-Chloro-6-(1H-imidazol-1-yl)pyridazine → 1'-[6-(1H-imidazol-1-yl)pyridazin-3-yl]-3H-spiro[2-benzofuran-1,3'-pyrrolidine]
反応式
Cl[C:2]1[N:3]=[N:4][C:5]([N:8]2[CH:12]=[CH:11][N:10]=[CH:9]2)=[CH:6][CH:7]=1.Cl.[NH:14]1[CH2:18][CH2:17][C:16]2([C:22]3[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=3[CH2:20][O:19]2)[CH2:15]1>C(N(CC)CC)C>[N:8]1([C:5]2[N:4]=[N:3][C:2]([N:14]3[CH2:18][CH2:17][C:16]4([C:22]5[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=5[CH2:20][O:19]4)[CH2:15]3)=[CH:7][CH:6]=2)[CH:12]=[CH:11][N:10]=[CH:9]1参加物
4
実験手順
The object product (195 mg, 61%) was obtained in the same manner as in Example 165 and using 3-chloro-6-(1H-imidazol-1-yl)pyridazine (180 mg), 3H-spiro[2-benzofuran-1,3′-pyrrolidine] hydrochloride (200 mg) obtained in Example 43(5) and triethylamine (0.42 mL).
出典と根拠
- ORDレコード
- ord-d579883652a64e258855bde991d36576
- 出典データセット
- uspto-grants-2013_11
- 特許番号
- US08575167B2
反応ノート
読み込み中…